aztreonam has been researched along with Opportunistic Infections in 5 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cellulitis is usually caused by organisms such as beta-hemolytic streptococci and Staphylococcus aureus." | 1.32 | Sepsis in a renal transplant recipient due to Citrobacter braakii. ( Agraharkar, ML; Gupta, R; Rauf, SJ; Singh, S; Smith, J, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fleming, DR | 1 |
| Ziegler, C | 1 |
| Baize, T | 1 |
| Mudd, L | 1 |
| Goldsmith, GH | 1 |
| Herzig, RH | 1 |
| Gupta, R | 1 |
| Rauf, SJ | 1 |
| Singh, S | 1 |
| Smith, J | 1 |
| Agraharkar, ML | 1 |
| Raad, I | 1 |
| Hachem, R | 1 |
| Hanna, H | 1 |
| Abi-Said, D | 1 |
| Bivins, C | 1 |
| Walsh, G | 1 |
| Thornby, J | 1 |
| Whimbey, E | 1 |
| Huaringa, A | 1 |
| Sukumaran, A | 1 |
| Sakata, Y | 1 |
| Sawada, Y | 1 |
| Kuroe, K | 1 |
| Nakaji, S | 1 |
| Takami, H | 1 |
| Tsushima, K | 1 |
| Saito, S | 1 |
| Ogasawara, H | 1 |
| Shinagawa, H | 1 |
| Soma, N | 1 |
| Sakata, H | 1 |
| Kakehashi, H | 1 |
| Fujita, K | 1 |
| Yoshioka, H | 1 |
3 trials available for aztreonam and Opportunistic Infections
| Article | Year |
|---|---|
Cefepime versus ticarcillin and clavulanate potassium and aztreonam for febrile neutropenia therapy in high-dose chemotherapy patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Aztreonam; Cefepime; Cephalosporins; Clav | 2003 |
Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study.
Topics: Aged; Amikacin; Aztreonam; Chi-Square Distribution; Clindamycin; Cross Infection; Drug Therapy, Comb | 2001 |
[A randomized controlled study on imipenem/cilastatin sodium in comparison to aztreonam + lincomycin in treating severe infections in patients with malignant tumors or hematological diseases].
Topics: Adolescent; Adult; Aged; Aztreonam; Cilastatin; Drug Therapy, Combination; Female; Hematologic Disea | 1992 |
2 other studies available for aztreonam and Opportunistic Infections
| Article | Year |
|---|---|
Sepsis in a renal transplant recipient due to Citrobacter braakii.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Bacteremia; Cellulitis; Citrobacter freundi | 2003 |
[Selective decontamination of intestinal flora with oral aztreonam in compromised children].
Topics: Administration, Oral; Adolescent; Aztreonam; Child; Child, Preschool; Colony Count, Microbial; Decon | 1989 |